Potent anti-tumor effect generated by a novel human papillomavirus (HPV) antagonist peptide reactivating the pRb/E2F pathway.
Human papillomavirus type 16 (HPV16) E7 is a viral oncoprotein believed to play a major role in cervical cancer. In this study, an antagonist peptide against HPV16E7 protein was first identified from screening the c7c phage display peptide library. The binding specificity and affinity of the selecte...
Main Authors: | Cai-ping Guo, Ke-wei Liu, Hai-bo Luo, Hong-bo Chen, Yi Zheng, Shen-nan Sun, Qian Zhang, Laiqiang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3057995?pdf=render |
Similar Items
-
Aberrant Expression of Rb and pRb-780, pRb-795 in Lung Adenocarcinoma Patients with EGFR Mutations and Their Clinical Significance
by: Yunlong DONG, et al.
Published: (2017-05-01) -
CDK4, pRB and E2F1: connected to insulin
by: Blanchet Emilie, et al.
Published: (2010-02-01) -
The role and regulation of the pRB/E2F pathway in B-lymphocytes
by: Banerji, Lolita
Published: (2002) -
Molecular analysis of the role of E2F proteins in the pRB pathway
by: Moberg, Kenneth H. (Kenneth Harold), 1967-
Published: (2009) -
E2F4 cooperates with pRB in the development of extra-embryonic tissues
by: Lee, Eunice Y., et al.
Published: (2012)